Effect on patient management of a weekend 'on-call' nuclear medicine service

1993 ◽  
Vol 14 (3) ◽  
pp. 242
Author(s):  
N. Carter ◽  
C. Eustance ◽  
M. O??Doherty ◽  
A. J. Coakley
1994 ◽  
Vol 15 (5) ◽  
pp. 388-391???391 ◽  
Author(s):  
C. EUSTANCE ◽  
N. CARTER ◽  
M. O??DOHERTY ◽  
A. J. COAKLEY

2020 ◽  
Vol 13 (3) ◽  
pp. 39
Author(s):  
Irina Velikyan

The role of nuclear medicine in the management of oncological patients has expanded during last two decades. The number of radiopharmaceuticals contributing to the realization of theranostics/radiotheranostics in the context of personalized medicine is increasing. This review is focused on the examples of targeted (radio)pharmaceuticals for the imaging and therapy of neuroendocrine neoplasms (NENs), prostate cancer, and breast cancer. These examples strongly demonstrate the tendency of nuclear medicine development towards personalized medicine.


2020 ◽  
Vol 47 (7) ◽  
pp. 1645-1648 ◽  
Author(s):  
Winnie Wing-Chuen Lam ◽  
Kelvin Siu-Hoong Loke ◽  
Wai Yin Wong ◽  
David Chee-Eng Ng

2021 ◽  
Vol 8 ◽  
Author(s):  
James R. Crowley ◽  
Iryna Barvi ◽  
Debbie Greulich ◽  
Jackson W. Kiser

Nuclear medicine extravasations and prolonged venous stasis may cause poor quality and quantification errors that can affect image interpretation and patient management. Radiopharmaceutical remaining near the administration site means that some portion of the radioactivity is not circulating as required for the prescribed uptake period. This case describes how detection of excess presence of 99mTc-MDP near the injection site enabled the technologist to apply mitigation tactics early in the uptake process. It also suggests that detecting an extravasation or stasis early in the injection process can be important for image interpretation and minimizing radiation dose to tissue.


Author(s):  
M. Reyes-Pérez ◽  
M.I. Rodrigo-Rincón ◽  
M.E. Martínez-Lozano ◽  
E. Goñi-Gironés ◽  
A. Camarero-Salazar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document